In this video

Share

Regeneron CEO: We'll likely have to constantly adapt our antibody cocktail

Dr. Leonard Schleifler, founder and CEO of Regeneron, joins "Squawk Box" to discuss the company's monoclonal antibody treatment and the omicron variant.
04:09
Tue, Nov 30 20219:25 AM EST